Research Paper Volume 15, Issue 9 pp 3572—3585
Increased SEMA6B expression as a potential prognostic and immune cell infiltration biomarker in thyroid cancer patients
Figure 1. (A) RNA sequencing data analysis on SEMA6B mRNA expression differences between normal and thyroid cancer (THCA) tissues. (B) RNA sequencing validation on SEMA6B mRNA expression in paired samples of THCA and normal thyroid tissues. Data were retrieved from publicly available online platform GTEx (C–F) ROC curve for SEMA6B in THCA samples.